Skip to content

ANAFARMA: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ANAFARMA

BE 0833.976.009
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€3,778
2024 · €11,749-€7,970
Equity
€313,517
2024 · €309,738+€3,778
Cash
€50,160
2024 · €82,967-€32,806
Balance sheet total
€474,117
2024 · €483,817-€9,699

Largest movements

2024 to 2025
Assets
  • Cash -€32,806

    down €32,806 (-39.5%), from €82,967 to €50,160

    mainly Current investments (-€30,968) and Debts after one year (-€10,403)

  • Current investments +€30,968

    up €30,968 (+23.7%), from €130,589 to €161,556

  • Tangible fixed assets -€18,802

    down €18,802 (-26.1%), from €72,018 to €53,216

    of which Furniture and vehicles: -€17,241

  • Receivables within one year +€9,441

    up €9,441 (+4.8%), from €196,622 to €206,063

    of which Trade receivables: +€9,820

Equity and liabilities
  • Debts after one year -€10,403

    down €10,403 (-28.0%), from €37,166 to €26,764

Income statement
  • Gross operating margin -€10,765

    down €10,765 (-23.6%), from €45,563 to €34,798

  • Taxes -€2,973

    down €2,973 (-46.8%), from €6,354 to €3,382

  • Depreciation +€2,013

    up €2,013 (+12.0%), from €16,789 to €18,802

  • Financial charges -€955

    down €955 (-9.0%), from €10,667 to €9,713

  • Financial income +€847

    up €847 (+121.3%), from €699 to €1,546

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €11,749
Gross operating margin -€10,765
Depreciation -€2,013
Other operating charges +€34
Financial income +€847
Financial charges +€955
Taxes +€2,973
Result 2025 €3,778

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€11,524
Investment -€30,968
Financing -€13,363
Cash 2024 €82,967
Net result for the year +€3,778
Depreciation +€18,802
Receivables within one year -€9,441
Deferred charges and accrued income -€1,501
Trade debts +€2,581
Tax, wage and social debts +€887
Other debts -€2,487
Accrued charges and deferred income -€1,095
Current investments -€30,968
Debts after one year -€10,403
Current portion of long-term debt -€2,960
Cash 2025 €50,160
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €483,817 €474,117 -€9,699 -2.0%
Fixed assets 21/28 €72,018 €53,216 -€18,802 -26.1%
Tangible fixed assets 22/27 €72,018 €53,216 -€18,802 -26.1%
Furniture and vehicles 24 €63,618 €46,377 -€17,241 -27.1%
Other tangible fixed assets 26 €8,400 €6,840 -€1,561 -18.6%
Current assets 29/58 €411,798 €420,901 +€9,103 +2.2%
Amounts receivable within one year 40/41 €196,622 €206,063 +€9,441 +4.8%
Trade receivables 40 €8,240 €18,060 +€9,820 +119.2%
Other amounts receivable 41 €188,382 €188,003 -€379 -0.2%
Current investments 50/53 €130,589 €161,556 +€30,968 +23.7%
Cash at bank and in hand 54/58 €82,967 €50,160 -€32,806 -39.5%
Deferred charges and accrued income 490/1 €1,620 €3,121 +€1,501 +92.6%
Total equity and liabilities 10/49 €483,817 €474,117 -€9,699 -2.0%
Equity 10/15 €309,738 €313,517 +€3,778 +1.2%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €297,338 €301,117 +€3,778 +1.3%
Distributable reserves 133 €297,338 €301,117 +€3,778 +1.3%
Amounts payable 17/49 €174,078 €160,601 -€13,478 -7.7%
Amounts payable after more than one year 17 €37,166 €26,764 -€10,403 -28.0%
Financial debts 170/4 €37,166 €26,764 -€10,403 -28.0%
Amounts payable within one year 42/48 €128,013 €126,034 -€1,980 -1.5%
Current portion of amounts payable after more than one year 42 €13,363 €10,403 -€2,960 -22.2%
Trade debts 44 €2,199 €4,780 +€2,581 +117.3%
Suppliers 440/4 €2,199 €4,780 +€2,581 +117.3%
Taxes, remuneration and social security 45 €985 €1,873 +€887 +90.1%
Taxes 450/3 €985 €1,873 +€887 +90.1%
Other amounts payable 47/48 €111,466 €108,978 -€2,487 -2.2%
Accrued charges and deferred income 492/3 €8,899 €7,804 -€1,095 -12.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €16,789 €18,802 +€2,013 +12.0%
Other operating charges 640/8 €702 €669 -€34 -4.8%
Gross operating margin 9900 €45,563 €34,798 -€10,765 -23.6%
Operating profit (loss) 9901 €28,072 €15,327 -€12,745 -45.4%
Financial income 75/76B €699 €1,546 +€847 +121.3%
Recurring financial income 75 €699 €1,546 +€847 +121.3%
Financial charges 65/66B €10,667 €9,713 -€955 -9.0%
Recurring financial charges 65 €10,667 €9,713 -€955 -9.0%
Profit (loss) for the period before taxes 9903 €18,103 €7,160 -€10,943 -60.4%
Income taxes 67/77 €6,354 €3,382 -€2,973 -46.8%
Profit (loss) for the period 9904 €11,749 €3,778 -€7,970 -67.8%
Profit (loss) for the period to be appropriated 9905 €11,749 €3,778 -€7,970 -67.8%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.